Skip to main content
. 2015 Jun 11;4(6):e001225. doi: 10.1161/JAHA.114.001225

Table 6.

Patient Characteristics Among the Subset of Patients Admitted to Cardiology-Specific ICUs

Characteristic LMIV Patients (n=60) HMIV Patients (n=12 907) P Value
Demographics
 Age, y 66±12 63±14 0.09
 Female sex, % 37 33 0.56
 White race, % 77 81 0.38
 Body-mass index, kg/m2 30±7 30±11 0.97
Medical history
 Diabetes, % 22 19 0.53
 Hypertension, % 23 23 1.00
 Dyslipidemia, % 18 13 0.19
 Cerebrovascular disease, % 2 1 0.46
 AMI in past 6 months, % 7 3 0.08
 Systolic heart failure, % 18 5 <0.001
 Chronic kidney disease, % 7 5 0.43
 Chronic lung disease, % 7 6 0.88
AMI location
 Anterior, % 20 21 0.88
 Inferior, % 20 33 0.027
 Non-Q-wave AMI, % 43 33 0.09
Objective findings at ICU admission
 Mean blood pressure, mm Hg 84±18 88±17 0.045
 Heart rate, beats per minute 86±19 78±16 <0.001
 White blood cell count, ×1000/μL 12±5 11±4 0.054
 Hemoglobin, g/dL 12±2 13±2 0.10
 Creatinine, mg/dL 1.3±1 1.1±1 0.11
 Glucose, mg/dL 148±67 146±69 0.78
 Troponin-I, ng/mL 25±53 35±70 0.52
 Troponin-T, ng/mL 3±3 5±11 0.35
Worst laboratory studies within 72 hours
 Lowest hemoglobin, g/dL 11±2 12±2 <0.001
 Highest creatinine, mg/dL 1.6±1 1.3±1 0.033
 Highest glucose, mg/dL 214±96 178±92 0.003
 Peak troponin-I, ng/mL 27±53 44±78 0.33
 Peak troponin-T, ng/mL 4±4 6±12 0.38
Major interventions during first 24 hours
 Thrombolytic therapy, % 13 22 0.10
 Percutaneous coronary intervention, % 83 75 0.15
 Endotracheal intubation, % 28 5 <0.001
 Inotropic or pressor support, % 12 5 0.009
APACHE-IV 52±28 41±19 <0.001
APS 40±26 30±17 <0.001

Values are expressed as percentages or mean±standard deviation. AMI indicates acute myocardial infarction; APACHE-IV, Acute Physiology and Chronic Health Evaluation, Fourth Revision; APS, Acute Physiology Score; HMIV and LMIV, high and low annual volume of acute myocardial infarction, respectively; ICU, intensive care unit.